IL161500A0 - Taste masking spill-resistant formulation - Google Patents

Taste masking spill-resistant formulation

Info

Publication number
IL161500A0
IL161500A0 IL16150002A IL16150002A IL161500A0 IL 161500 A0 IL161500 A0 IL 161500A0 IL 16150002 A IL16150002 A IL 16150002A IL 16150002 A IL16150002 A IL 16150002A IL 161500 A0 IL161500 A0 IL 161500A0
Authority
IL
Israel
Prior art keywords
taste masking
resistant formulation
spill
base
pharmaceutical agent
Prior art date
Application number
IL16150002A
Other languages
English (en)
Original Assignee
Taro Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taro Pharma Ind filed Critical Taro Pharma Ind
Publication of IL161500A0 publication Critical patent/IL161500A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16150002A 2001-10-22 2002-10-22 Taste masking spill-resistant formulation IL161500A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33044701P 2001-10-22 2001-10-22
PCT/US2002/033478 WO2003034991A2 (fr) 2001-10-22 2002-10-22 Dissimulation du gout de formulation resistante a l'ecoulement

Publications (1)

Publication Number Publication Date
IL161500A0 true IL161500A0 (en) 2004-09-27

Family

ID=23289820

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16150002A IL161500A0 (en) 2001-10-22 2002-10-22 Taste masking spill-resistant formulation
IL161500A IL161500A (en) 2001-10-22 2004-04-19 Taste masking spill-resistant formulation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161500A IL161500A (en) 2001-10-22 2004-04-19 Taste masking spill-resistant formulation

Country Status (12)

Country Link
EP (1) EP1438026B1 (fr)
JP (3) JP2005506993A (fr)
KR (1) KR20040084891A (fr)
CN (1) CN1571661A (fr)
AT (1) ATE505183T1 (fr)
AU (1) AU2002356831B2 (fr)
BR (1) BR0213379A (fr)
CA (2) CA2466036C (fr)
DE (1) DE60239752D1 (fr)
IL (2) IL161500A0 (fr)
MX (1) MXPA04003789A (fr)
WO (1) WO2003034991A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5398100B2 (ja) * 2003-06-23 2014-01-29 大正製薬株式会社 鉄化合物を含む内服液剤組成物
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
GB2430364A (en) * 2005-09-22 2007-03-28 Carl Ernest Alexander Soft agar bolus for oral drug delivery
EP1928268A1 (fr) * 2005-09-30 2008-06-11 DSMIP Assets B.V. Nouvelles préparations contenant des polyphénols
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN101374510A (zh) * 2006-01-25 2009-02-25 塔罗制药北美有限公司 抗组胺组合物及其应用
EP2313083A1 (fr) * 2008-07-22 2011-04-27 Lupin Limited Compositions orales de clindamycine
WO2010144865A2 (fr) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Procédés de traitement de troubles gastro-intestinaux
EP3064064A1 (fr) 2009-09-30 2016-09-07 Acura Pharmaceuticals, Inc. Procédés et compositions de dissuasion d'abus
FR2987268B1 (fr) 2012-02-28 2014-07-11 Ammtek Formulations liquides de sulfamides hypoglycemiants
CN107595793B (zh) 2012-11-30 2020-11-13 阿库拉制药公司 活性药物成分的自调节释放
CN105263524A (zh) * 2013-03-15 2016-01-20 诺瓦蒂斯消费者健康股份有限公司 无染料的液体治疗溶液
CA2919892C (fr) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Comprime extrude anti-abus a liberation immediate
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (fr) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Comprimé extrudé anti-abus à libération prolongée
EP3169315B1 (fr) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Forme posologique remplie de liquide anti-abus à libération immédiate
WO2016064873A1 (fr) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Forme galénique anti-abus de remplissage de liquide à libération prolongée
WO2017040607A1 (fr) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Procédés et compositions pour la libération auto-régulée d'un ingrédient pharmaceutique actif
CA3045118A1 (fr) 2016-11-28 2018-05-31 Johnson & Johnson Consumer Inc. Compositions liquides comprenant un agent mucoadhesif
NL2024161B1 (en) * 2019-11-05 2021-07-20 Mperium B V Pharmaceutical liquid composition, kit of parts comprising the pharmaceutical liquid composition, and method for preparing the pharmaceutical liquid composition
CN112274483A (zh) * 2020-10-28 2021-01-29 河北冀衡药业股份有限公司 一种对乙酰氨基酚混悬滴剂及其制备方法
EP4368171A1 (fr) * 2022-11-08 2024-05-15 Laboratorios Ern S.A. Solution orale de paracetamol

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
US4806354A (en) * 1984-04-06 1989-02-21 Green James P Health food composition
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
US5563177A (en) * 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6010683A (en) * 1997-11-05 2000-01-04 Ultradent Products, Inc. Compositions and methods for reducing the quantity but not the concentration of active ingredients delivered by a dentifrice
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form

Also Published As

Publication number Publication date
WO2003034991A3 (fr) 2004-02-26
AU2002356831B2 (en) 2006-06-08
DE60239752D1 (de) 2011-05-26
WO2003034991A2 (fr) 2003-05-01
CA2764642A1 (fr) 2003-05-01
CA2466036A1 (fr) 2003-05-01
IL161500A (en) 2012-10-31
JP2005506993A (ja) 2005-03-10
MXPA04003789A (es) 2005-06-03
CN1571661A (zh) 2005-01-26
EP1438026A2 (fr) 2004-07-21
JP5185844B2 (ja) 2013-04-17
KR20040084891A (ko) 2004-10-06
JP2009102389A (ja) 2009-05-14
ATE505183T1 (de) 2011-04-15
JP2013014626A (ja) 2013-01-24
CA2466036C (fr) 2012-04-24
BR0213379A (pt) 2005-02-01
EP1438026A4 (fr) 2005-08-03
EP1438026B1 (fr) 2011-04-13

Similar Documents

Publication Publication Date Title
IL161500A0 (en) Taste masking spill-resistant formulation
WO2002080976A3 (fr) Formulations d'interferon beta exemptes d'albumine serique humaine
HK1080364A1 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
WO2003045331A3 (fr) Preparations pour une administration par voie orale d'acide cromoglycique
EP1246608A4 (fr) Formulations pharmaceutiques pour l'administration de medicaments ayant une faible solubilite aqueuse
HUP0300207A3 (en) 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
CA2189328A1 (fr) Compositions de tocopherol destinees a l'apport d'agents biologiquement actifs
HUP0203168A2 (hu) Készítmények nyálkahártyán át történő beadásra
MY129406A (en) Taste masked liquid pharmaceutical compositions
WO2005065646A3 (fr) Compositions medicamenteuses et formes pharmaceutiques
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
AU3085102A (en) Drug delivery compositions and medical devices containing block copolymer
EE05089B1 (et) Amiidasendatud imidasokinoliinid ja neid sisaldavad farmatseutilised preparaadid
MY129350A (en) Aripiprazole oral solution
MY111177A (en) Flavour-masked pharmaceutical compositions
HUP0104934A3 (en) Peptide analogues of pacap, pharmaceutical compositions comprising thereof and their use
HUP0400246A3 (en) 1,2,4-trioxolane antimalarial pharmaceutical compositions and process for their preparation and use
HUP0401174A3 (en) Ecteinascidin analogues, their use in the preparation of a medicament for treatment of cancer and pharmaceutical compositions containing the compounds
WO2000021510A3 (fr) Nouvelles formulations de fexofenadine
WO2000050046A8 (fr) Composition pharmaceutique orale stabilisee contenant de l'iodure et de l'iodate et procede associe
ATE287264T1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
HUP0400494A3 (en) Polyamine analogues as cytotoxic agents and pharmaceutical compositions containing them
ATE230258T1 (de) Injizierbares arzneimittel auf basis eines pharmazeutisch verträglichen salzes von clopidogrel bzw. von ticlopidin
WO2002015892A3 (fr) Combinaisons
WO2003018535A3 (fr) Nouvelles aminobenzophenones